Bowling Green, KY2 Active Studies

Interstitial Cystitis Clinical Trials in Bowling Green, KY

Find 2 actively recruiting interstitial cystitis clinical trials in Bowling Green, KY. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
705
Enrolling

Recruiting Interstitial Cystitis Studies in Bowling Green

About Interstitial Cystitis Clinical Trials in Bowling Green

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 2 interstitial cystitis clinical trials recruiting participants in Bowling Green, KY. These studies are seeking a combined 705 participants. Research is being sponsored by Takeda, Blueprint Medicines Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Bowling Green — FAQ

Are there interstitial cystitis clinical trials in Bowling Green?

Yes, there are 2 interstitial cystitis clinical trials currently recruiting in Bowling Green, KY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bowling Green?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bowling Green research site will contact you about next steps.

Are clinical trials in Bowling Green free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bowling Green studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 2 active trials in Bowling Green are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov